Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v2-FR
Language English French
Date Updated 2018-12-08 2018-11-16
Drug Identification Number 00506052 00506052
Brand name APO IBUPROFEN TAB 400MG APO IBUPROFEN TAB 400MG
Common or Proper name IBUPROFEN TAB 400MG IBUPROFEN TAB 400MG
Company Name APOTEX INC APOTEX INC
Ingredients IBUPROFEN IBUPROFEN
Strength(s) 400MG 400MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 1000 BTL 1000 BTL
ATC code M01AE M01AE
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-11-12 2018-11-12
Estimated end date Unknown Unknown
Actual end date 2018-12-07
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments